
Ana Lucrecia Woodward
Examiner (ID: 7465, Phone: (571)272-1082 , Office: P/1765 )
| Most Active Art Unit | 1765 |
| Art Unit(s) | 1796, 1501, 1711, 1765, 1512, 1314, 1504 |
| Total Applications | 3148 |
| Issued Applications | 2104 |
| Pending Applications | 173 |
| Abandoned Applications | 906 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11230893
[patent_doc_number] => 09458113
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-10-04
[patent_title] => 'Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity'
[patent_app_type] => utility
[patent_app_number] => 14/809314
[patent_app_country] => US
[patent_app_date] => 2015-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29817
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14809314
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/809314 | Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity | Jul 26, 2015 | Issued |
Array
(
[id] => 11250288
[patent_doc_number] => 09475779
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-10-25
[patent_title] => 'Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity'
[patent_app_type] => utility
[patent_app_number] => 14/809307
[patent_app_country] => US
[patent_app_date] => 2015-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24147
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14809307
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/809307 | Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity | Jul 26, 2015 | Issued |
Array
(
[id] => 13325837
[patent_doc_number] => 20180214456
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-02
[patent_title] => ORBIT AZINE-FUMARATE, HYDRATE, CRYSTAL FORM AND PREPARATION METHOD THEREFOR
[patent_app_type] => utility
[patent_app_number] => 15/747416
[patent_app_country] => US
[patent_app_date] => 2015-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13114
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15747416
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/747416 | Orbit azine-fumarate, hydrate, crystal form and preparation method therefor | Jul 23, 2015 | Issued |
Array
(
[id] => 11943236
[patent_doc_number] => 20170247387
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-31
[patent_title] => 'UREA/CARBAMATES FAAH MAGL OR DUAL FAAH/MAGL INHIBITORS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/328428
[patent_app_country] => US
[patent_app_date] => 2015-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35434
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15328428
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/328428 | Urea/carbamates FAAH MAGL or dual FAAH/MAGL inhibitors and uses thereof | Jul 23, 2015 | Issued |
Array
(
[id] => 11821810
[patent_doc_number] => 20170210747
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-27
[patent_title] => '[1,2,4]TRIAZOLO[4,3-B]PYRIDAZINES FOR USE IN THE TREATMENT OF PROLIFERATIVE DISEASES'
[patent_app_type] => utility
[patent_app_number] => 15/329274
[patent_app_country] => US
[patent_app_date] => 2015-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 21657
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15329274
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/329274 | [1,2,4]triazolo[4,3-B]pyridazines for use in the treatment of proliferative diseases | Jul 23, 2015 | Issued |
Array
(
[id] => 11283723
[patent_doc_number] => 09499567
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-11-22
[patent_title] => 'Piperidine/piperazine derivatives'
[patent_app_type] => utility
[patent_app_number] => 14/803275
[patent_app_country] => US
[patent_app_date] => 2015-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32321
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14803275
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/803275 | Piperidine/piperazine derivatives | Jul 19, 2015 | Issued |
Array
(
[id] => 13236957
[patent_doc_number] => 10131669
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-11-20
[patent_title] => Pyrazolopyrimidine compounds
[patent_app_type] => utility
[patent_app_number] => 15/327814
[patent_app_country] => US
[patent_app_date] => 2015-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26093
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15327814
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/327814 | Pyrazolopyrimidine compounds | Jul 9, 2015 | Issued |
Array
(
[id] => 10414187
[patent_doc_number] => 20150299197
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-22
[patent_title] => 'APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES'
[patent_app_type] => utility
[patent_app_number] => 14/789449
[patent_app_country] => US
[patent_app_date] => 2015-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40298
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14789449
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/789449 | APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES | Jun 30, 2015 | Abandoned |
Array
(
[id] => 11956009
[patent_doc_number] => 20170260161
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-14
[patent_title] => 'BI-BENZYL ISOQUINOLINE DERIVATIVE, PREPARATION METHOD AND USE THEREOF IN HEPATOPATHY TREATMENT AND PREVENTION'
[patent_app_type] => utility
[patent_app_number] => 15/504245
[patent_app_country] => US
[patent_app_date] => 2015-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25249
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15504245
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/504245 | Bi-benzyl isoquinoline derivative, preparation method and use thereof in hepatopathy treatment and prevention | Jun 28, 2015 | Issued |
Array
(
[id] => 10412580
[patent_doc_number] => 20150297589
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-22
[patent_title] => 'TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM'
[patent_app_type] => utility
[patent_app_number] => 14/753435
[patent_app_country] => US
[patent_app_date] => 2015-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5071
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14753435
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/753435 | TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM | Jun 28, 2015 | Abandoned |
Array
(
[id] => 10467095
[patent_doc_number] => 20150352110
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-10
[patent_title] => 'SUBSTITUTED OXINDOLE DERIVATIVES AND THEIR USE AS VASOPRESSIN RECEPTOR LIGANDS'
[patent_app_type] => utility
[patent_app_number] => 14/740598
[patent_app_country] => US
[patent_app_date] => 2015-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28945
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14740598
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/740598 | SUBSTITUTED OXINDOLE DERIVATIVES AND THEIR USE AS VASOPRESSIN RECEPTOR LIGANDS | Jun 15, 2015 | Abandoned |
Array
(
[id] => 11589642
[patent_doc_number] => 20170114053
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-27
[patent_title] => 'HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/317864
[patent_app_country] => US
[patent_app_date] => 2015-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11639
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15317864
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/317864 | Heterocyclic compounds and methods of use thereof | Jun 11, 2015 | Issued |
Array
(
[id] => 10476081
[patent_doc_number] => 20150361099
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-17
[patent_title] => 'PROCESSES FOR MAKING ALKYLATED ARYLPIPERAZINE AND ALKYLATED ARYLPIPERIDINE COMPOUNDS INCLUDING NOVEL INTERMEDIATES'
[patent_app_type] => utility
[patent_app_number] => 14/737599
[patent_app_country] => US
[patent_app_date] => 2015-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8427
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14737599
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/737599 | Processes for making alkylated arylpiperazine and alkylated arylpiperidine compounds including novel intermediates | Jun 11, 2015 | Issued |
Array
(
[id] => 13139719
[patent_doc_number] => 10087180
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-02
[patent_title] => Pyrazolo-pyridine derivatives as kinase inhibitors
[patent_app_type] => utility
[patent_app_number] => 15/318473
[patent_app_country] => US
[patent_app_date] => 2015-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20274
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15318473
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/318473 | Pyrazolo-pyridine derivatives as kinase inhibitors | Jun 10, 2015 | Issued |
Array
(
[id] => 12009640
[patent_doc_number] => 09802945
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-31
[patent_title] => 'Imidazopyridazine derivatives as modulators of the GABAA receptor activity'
[patent_app_type] => utility
[patent_app_number] => 15/316552
[patent_app_country] => US
[patent_app_date] => 2015-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23453
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15316552
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/316552 | Imidazopyridazine derivatives as modulators of the GABAA receptor activity | Jun 2, 2015 | Issued |
Array
(
[id] => 11971121
[patent_doc_number] => 20170275275
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-28
[patent_title] => 'BENZENESULFONAMIDES USEFUL AS SODIUM CHANNEL INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 15/310113
[patent_app_country] => US
[patent_app_date] => 2015-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39511
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15310113
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/310113 | BENZENESULFONAMIDES USEFUL AS SODIUM CHANNEL INHIBITORS | May 28, 2015 | Abandoned |
Array
(
[id] => 10444532
[patent_doc_number] => 20150329543
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-19
[patent_title] => 'PRODRUGS OF SUBSTITUTED AZAINDOLEOXOACETIC PIPERAZINE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 14/725318
[patent_app_country] => US
[patent_app_date] => 2015-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 100053
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14725318
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/725318 | PRODRUGS OF SUBSTITUTED AZAINDOLEOXOACETIC PIPERAZINE DERIVATIVES | May 28, 2015 | Abandoned |
Array
(
[id] => 10374338
[patent_doc_number] => 20150259342
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-17
[patent_title] => 'SUBSTITUTED AZAINDOLEOXOACETIC PIPERAZINE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 14/725298
[patent_app_country] => US
[patent_app_date] => 2015-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 99927
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14725298
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/725298 | SUBSTITUTED AZAINDOLEOXOACETIC PIPERAZINE DERIVATIVES | May 28, 2015 | Abandoned |
Array
(
[id] => 11743907
[patent_doc_number] => 20170197978
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-13
[patent_title] => 'NOVEL COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 15/314111
[patent_app_country] => US
[patent_app_date] => 2015-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 73376
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15314111
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/314111 | Heteroaryl substituted compounds as RORγ inhibitors | May 25, 2015 | Issued |
Array
(
[id] => 10389699
[patent_doc_number] => 20150274707
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-01
[patent_title] => 'PROCESS FOR THE PREPARATION OF N-[5-(3,5-DIFLUORO-BENZYL)-1H-INDAZOL-3-YL]-4-(4-METHYL-PIPERAZIN-1-YL)-2-(TETRAHYDRO-PYRAN-4-YLAMINO)-BENZAMIDE'
[patent_app_type] => utility
[patent_app_number] => 14/716986
[patent_app_country] => US
[patent_app_date] => 2015-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 7713
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14716986
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/716986 | Unsolvated crystalline form 1 of N-[5-(3, 5-difluoro-benzyl)-1H-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydro-pyran-4-ylamino)-benzamide and methods of use thereof | May 19, 2015 | Issued |